Frontotemporal dementia (FTD) is characterised by disturbances in behaviour or language. Patients with the frontal variant of FTD typically present with marked changes in personality and behaviour, including apathy, disinhibition and inappropriate social behaviour, which can be difficult to manage.
Although there is currently no approved drug treatment for the behavioural symptoms of FTD and only a limited number of clinical trials have been conducted in this area, various medications have been used to ameliorate these symptoms.
Read the complete bulletin:
A joint initiative of the Patient Services Section and the Drug and Therapeutics Information Service of the Pharmacy Department, Repatriation General Hospital, Daw Park, South Australia. The RGH Pharmacy E-Bulletin is distributed in electronic format on a weekly basis, and aims to present concise, factual information on issues of current interest in therapeutics, drug safety and cost-effective use of medications.
Editor: Assoc. Prof. Chris Alderman, University of South Australia – Director of Pharmacy, RGH © Pharmacy Department, Repatriation General Hospital, Daw Park, South Australia 5041.